Yinzhihuang injection as adjuvant treatment for neonatal hyperbilirubinemia: a systematic review and meta-analysis of randomized clinical trials
2024

Yinzhihuang Injection for Treating Neonatal Jaundice

Sample size: 2714 publication Evidence: low

Author Information

Author(s): Li Junqiang, Zhang Liyu, Chen Zhongguo, Qin Min

Primary Institution: Lincang Maternity and Child Health Hospital, Lincang, Yunnan, China

Hypothesis

This study aims to evaluate the efficacy of Yinzhihuang injection on neonatal hyperbilirubinemia.

Conclusion

Yinzhihuang injection may offer superior benefits compared to routine treatment alone for neonatal hyperbilirubinemia, but further confirmation is needed.

Supporting Evidence

  • Twenty-two trials involving 2,714 neonates were included.
  • Significant differences were detected for total effective rate and serum bilirubin levels.
  • Adverse effects of YZH injection were described in four trials, with an incidence of 8.60%.

Takeaway

This study looked at a medicine called Yinzhihuang to see if it helps babies with yellow skin from jaundice. It seems to work better than just regular treatments.

Methodology

A systematic review and meta-analysis of randomized controlled trials was conducted, analyzing data from multiple databases.

Potential Biases

High risk of bias due to lack of blinding and incomplete outcome data in several studies.

Limitations

The majority of included studies had a high risk of bias and varied in quality, with limited long-term outcome data.

Participant Demographics

Participants were neonates with hyperbilirubinemia, with a mix of male and female infants.

Statistical Information

P-Value

<0.00001

Confidence Interval

95%CI: 1.11 to 1.20

Statistical Significance

p<0.00001

Digital Object Identifier (DOI)

10.3389/fphar.2024.1467325

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication